cnbc

cnbc

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    Even with mortgage rates at the lowest level in three months, homebuyers are pulling away from the housing market. Mortgage application volume fell 5.8 percent last week from the previous week, according to the Mortgage Bankers Association’s seasonally adjusted report. Buyers are still challenged by high prices and higher mortgage rates, and now some are clearly concerned about the steep drop in the stock market. “With rates continuing to slide lower, refinance borrowers with larger loan balance
    Mortgage applications fall 5.8% as stock market plunge unnerves buyers

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    Existing home sales up 1.9 percent in November18 Hours AgoCNBC’s Diana Olick reports on new numbers on existing home sales and first time homebuyers.
    Existing home sales up 1.9 percent in November

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    Australian Banks have gone ‘too far the other way’: SQM Research8 Hours AgoLouis Christopher of SQM Research weighs in on the regulatory picture for banks in Australia.
    Australian Banks have gone 'too far the other way': SQM Research

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    Sell, sell, sell.” I’ve got enough problems on my mind right now, right here, at this moment.” If that’s not a red flag, what’s a red flag? I’ve got to tell you, I don’t trust it. I don’t trust it.
    Cramer's lightning round: Sell Teva—debt is not king in this environment

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    With Amgen, Teva Pharmaceuticals and Eli Lilly all chasing market share with new drugs for treating migraines, the path to success is “a horse race between three great companies,” Eli Lilly’s CEO, Dave Ricks, told CNBC on Wednesday. In September, Eli Lilly received approval from the Food and Drug Administration for its migraine treatment, Emgality. You want an easy-to-use device patients can give themselves at home,” Ricks told Cramer. Eli Lilly shares gained 2.45 percent in Wednesday trading, s
    Eli Lilly on migraine treatment 'race' between Lilly, Amgen and Teva

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    Cramer: Charts suggest market pessimism is ‘overblown,’ stocks could be due for a bounce9 Hours AgoJim Cramer and technician Carley Garner take to the charts in light of the Federal Reserve’s interest rate hike to see what could be ahead for stocks.
    Cramer: Charts suggest market pessimism is 'overblown,' stocks could be due for a bounce

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    Shares of Micron shed more than 6 percent in after-hours trading following the company’s Tuesday earnings report, which missed analysts’ earnings and revenue estimates. “Our customers’ demand is strong,” he said on “Mad Money.” “Our customers’ demand from us is impacted in fiscal second quarter because of the inventory buildup. “The second half of the calendar year tends to be seasonally stronger for our industry. That’s why we are saying that by second half, we expect industry fundamentals to b
    Micron CEO touts 'vibrant' demand for key products as stock hits 52-week low after earnings

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    Walgreens Boots Alliance is teaming with Verily, Alphabet’s life sciences unit, on improving outcomes for patients with chronic conditions, the companies announced. Verily CEO Andrew Conrad said that working with Walgreens provides the health tech company “the opportunity to jointly tackle real-world issues that significantly impact the health of individuals and communities.” Both Walgreens and competitor CVS Health have mentioned lowering health-care costs for consumers as a priority in recent
    Walgreens to tackle health-care costs with Alphabet's Verily

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    Altria’s board of directors has approved its $12.8 billion investment in leading e-cigarette manufacturer Juul, with a formal announcement planned for Thursday before market open, people familiar with the matter told CNBC. Tobacco giant Altria will invest $12.8 billion for a 35 percent stake in Juul, which values the e-cigarette company at $38 billion, the people said. As such, Juul stipulated a number of conditions to help ensure the Altria deal furthers its goals. Right now, when smokers ditch
    Altria board approves $13 billion investment in e-cigarette company Juul

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    Canadian cannabis company Tilray entered a $100 million joint venture with beer brewer AB InBev to study cannabis-based beverages, the companies announced Wednesday. Constellation Brands, which sells Corona and Modelo in the U.S., has invested $4 billion in Canopy Growth, Canada’s largest medical marijuana producer. AB InBev’s Canada-based subsidiary, Labatt Breweries, will be involved in the Tilray partnership. News of the deal sent Tilray shares soaring as much as 22 percent. News of the deal
    Tilray shares surge after announcing $100 million deal with AB InBev to study cannabis-based drinks

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    Higher education in the United States is expensive:70 percent of college students graduate with student loans, and more than 44 million Americans currently hold $1.5 trillion in student debt. But paying for graduate school just got easier for 37-year-old Courtney Schlaud, who won $500,000 on CNBC’s “Deal or No Deal.” A lot of people said “trips,” she says, when contestants were asked during auditioning what they would most likely spend their money on if they won big on the show. Schlaud says her
    This 37-year-old won $500,000 on 'Deal or No Deal'—now she can afford to go to grad school

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    The rest of the money went toward Lubarsky’s first batch of inventory, nearly 100 different wholesale products (mostly health and personal care) that he knew would sell well based on his previous experience selling on Amazon. “They started selling. Let’s say, you know, 60 to 90 days went by — that $50,000 came back to us as [$70,000].” “We just kept selling stuff, taking the money, reinvesting it into new products.” At the time, Lubarsky tried to minimize any costs in order to keep reinvesting a
    How this high school dropout went from $100K in debt to bringing in $18M selling stuff on Amazon

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    The American health-care system is in a tug of war between physicians, hospitals, insurance companies, pharmaceuticals and shareholders. Ashley Palmiscino’s insurance company was billed roughly $4 million for her five-month-old son Luca’s lung transplant. Her family had to turn to fundraising almost immediately just to keep up with the medical bills, and she’s not alone. One-third of the money raised on GoFundMe last year went to medical campaigns. Watch the video above to follow the money throu
    Why medical bills in the US are so expensive

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    WASHINGTON — The White House on Wednesday struggled both to rationalize and to defend President Donald Trump’s surprise announcement that morning that the United States would withdraw its troops from Syria because, as Trump wrote in a tweet, “we have defeated ISIS in Syria.” It changed the news narrative — from one dominated by stories about Trump’s failure to secure the $5 billion he promised to get to build a border wall, to one dominated by coverage of what Trump’s Syria decision meant for th
    White House struggles to defend Trump's Syria withdrawal plan

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    CNBC’s Jim Cramer was surprised stocks didn’t plunge even further on the Federal Reserve’s Wednesday decision to hike interest rates by a quarter-point. “You could easily argue that we should’ve been down 1,000 Dow points. “Powell wants to put a stop to that. All in all, if you’re buying stocks at these levels, you’re fighting the Fed, and that’s a hard fight to win, Cramer warned. “Let me put it very simply: Powell wants a slower economy than we have.
    Cramer: Dow could have 'easily' been down 1,000 points on Fed hike

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    The S&P 500 lost 1.5 percent Wednesday to 2,506 and is nearly 15 percent off its September high. About 85 percent of the S&P 500 stocks have seen a correction of 10 percent or more, while 60 are in a bear market, meaning down 20 percent. Just last Friday the S&P 500 broke the neckline of a bearish head and shoulders top pattern, signaling more selling head. Redler said the best thing for the market would be a scary gap down for stocks Thursday because every morning this week , stocks opened high
    Stocks look to be in for more pain after Fed-day rout: 'The market is in no man's land'

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    Facebook on Wednesday evening published a blog post explaining why it allowed Spotify, Netflix and the Royal Bank of Canada to read, write and delete private user messages, as was reported by the New York Times on Tuesday. In its blog, Facebook said it gave these companies the ability to read, write and delete access to private messages so that users could communicate with one another using those third-party services. “No third party was reading your private messages, or writing messages to your
    Facebook explains how Netflix, Spotify, and others used the info they got

  • cnbc wrote a new post, (no title), on the site US Stock Info 7 years, 11 months ago

    To enforce privacy, Facebook needs third parties4 Hours AgoAsking the social media giant to enforce privacy is like asking wolves to protect sheep, explains Serguei Beloussov of Acronis.
    To enforce privacy, Facebook needs third parties

  • Square is making another attempt to break into banking. The start-up also issues small business loans through Square Capital. “We will continue to work closely with the FDIC and Utah DFI as they review our applications for Square Financial Services.” As a part of that request, Square named additional officers for the company including Brandon Soto, a former Green Dot executive who will serve as the chief financial officer of Square Financial Services. By green-lighting “Square Financial Services
    Square makes a second attempt to break into banking

  • But I’m content not using it as much in the future, and that’s the company’s bigger problem. And because Facebook offers so much targeting data with such a massive audience, brands just keep increasing their spending. It not just advertisers using that data. I never shut down my Friendster or MySpace accounts — my friends and I just stopped using them. So far, Facebook’s user numbers and engagement levels have consistently grown, quarter after quarter, allowing the company to see past its many d
    Facebook's biggest problem is that I can stop using it — and be just fine

  • Load More
Skip to toolbar